We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Cambridge Healthtech Institute to Host Second Annual "Next Generation Dx Summit: Moving Assays to the Clinic" in Washington, DC

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of " Cambridge Healthtech Institute to Host Second Annual "Next Generation Dx Summit: Moving Assays to the Clinic" in Washington, DC"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
Cambridge Healthtech Institute is hosting its second annual Next Generation Dx Summit on August 24-26, 2010 in Washington, DC. Building on last year's inaugural success, the Summit is designed to bring together all of the major players in the Molecular Diagnostics arena.

The four meetings comprising the event (Enabling Point-of-Care Diagnostics, Trends in Cancer Diagnostics, Molecular Diagnostics for Infectious Disease, and Co-Development of Drugs and Diagnostics) will showcase advances in technology, research, and diagnostic development, with an emphasis on applications to meet the demands of the clinic. The advance registration discount for the Summit ends this Friday, July 23, 2010.

The Next Generation Dx Summit will feature several interesting Keynote speakers, including: Jeffrey S. Ross, M.D., Albany Medical College and Foundation Medicine and Harry Glorikian, Managing Partner of Scientia Advisors, who will be talking about shaping the future of cancer pathway-based medicine. Franklin R. Cockerill, III, M.D., Mayo Medical Laboratories and Mayo Collaborative Services, Inc., and Christine C. Ginocchio, Ph.D., M.T. (ASCP), North Shore-LIJ Health System Laboratories, will be addressing the future of point-of-care for infectious disease.

The Summit features over 60 speakers who will present on topics covering trends for rapid diagnosis, early detection, novel therapies, and accelerating progress of companion diagnostics. Just a few of the confirmed speakers include: Hakan Sakul (Senior Director and Global Head, Pfizer Global R&D), Jeffery K. Taubenberger (Chief, Viral Pathogenesis, NIH), Steven Buchsbaum (Sr. Program Officer, Bill & Melinda Gates Foundation), Hans Lehrach (Director, Max Planck Institute for Molecular Genetics, Berlin), Gary W. Procop (Chair, Department of Molecular Pathology, Cleveland Clinic), Cathy Petti (Global Head, Novartis Infectious Disease & Diagnostics), Robert Dunstan (Distinguished Investigator, PCDS, Biogen Idec), and Cynthia Gawron-Burke (External Scientific Affairs, Merck Research Laboratories).

Additionally, there are two pre-conference short courses on Monday, August 23rd. These are dynamic, information-rich sessions. Topics include Commercialization of Molecular Diagnostics, and an Overview of Micro- and Nanofluidics. There is also a dinner short course on Wednesday, August 25th, on the Future of Point-of-Care Platforms.

Other highlights include break-out discussion groups, which offer the opportunity to discuss relevant topics in small group settings. This year's Exhibit Hall will feature an expanding number of exhibit booths and extensive poster presentations.